Congrats on both fronts - 1. New treatment for AML patients, and 2. To the team at AGIO for such a great success.

A few words about Michael. Michael D. Becker

Of all the bio industry reforms that are happening in China right now, the reimbursement of innovative medicines is by far the most important. It makes all the rest possible.

This one thing about which I am not the least uncertain.

Keith Ward, Ph.D. Joins as the Chief Development Officer of Unicycive prn.to/2Y7Rkg8

Unicycive Therapeutics Acquires Renazorb (Lanthanum Dioxycarbonate) from Spectrum Pharmaceuticals for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease prn.to/37ZowdM

Unicycive Therapeutics Announces Pricing of Initial Public Offering prn.to/3z6osVB

Unicycive Therapeutics Announces Second Quarter 2021 Financial Results prn.to/3g67aR3

Unicycive Therapeutics to be Added to Russell Microcap® Index prn.to/3EdhHod

Unicycive Therapeutics Appoints Douglas Jermasek as Executive Vice President, Corporate Strategy prn.to/3Eijo2G

Unicycive Therapeutics Announces Third Quarter 2021 Financial Results Expect to receive confirmatory guidance on Renazorb regulatory pathway from the U.S. Food and Drug Administration in Q4 2021 prn.to/3D75eBB

Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway On-track to submit New Drug Application in Q4 2022 prn.to/3cZ1nLm

Unicycive Announces Renazorb Pre-clinical and Clinical Data Selected for Presentation at National Kidney Foundation Spring Clinical Meeting prn.to/3AOZFaq

The entire team at B2i Digital is proud to welcome Unicycive Therapeutics Therapeutics, Inc. (NASDAQ: $UNCY) as a new member of our family of Featured Companies. Their B2i Digital profile is currently being developed. In the meantime, you are welcome to learn more at ir.unicycive.com

Thanks to the team Unicycive Therapeutics

Roche will have a bunch of interesting combo data w Tecentriq by YE: Anti-CEA x CD3 bi-spec Anti-OX40 Anti-CSF-1R Anti-CD40 Anti-CEA-IL2v FP

.Globavir dengue diagnostic, PanGlob™now approved in India for sales and distribution businesswire.com/news/home/2017…

.Globavir’s PanGlob Test Receives Approval for Sales and Distribution in India on.mktw.net/2jQVumZ

Very well written article --America’s ‘Miracle Machine’ is in desperate need of, well, a miracle wapo.st/2pPzm1y?tid=ss…

Excited about Globavir collaboration with SingHealth prnewswire.com/news-releases/…